OmniAb (OABI) Cash & Current Investments (2021 - 2026)
OmniAb's (OABI) quarterly Cash & Current Investments came in at $49.1 million in Q1 2026, up 12.56% year-on-year from $43.6 million in Q1 2025, and up 1.01% on a QoQ basis from $48.6 million in Q4 2025.
OmniAb (OABI) Cash & Current Investments (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Cash & Current Investments data on file, last reported at $49.1 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 12.56% year-over-year to $49.1 million in Q1 2026; TTM through Mar 2026 was $49.1 million, a 12.56% increase from a year earlier, with the FY2025 full-year figure at $48.6 million, down 18.26% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $49.1 million, up from $48.6 million in the prior quarter.
- Over the last five years, Cash & Current Investments for OABI reached as high as $113.6 million in Q1 2023 and fell as low as $19847.0 in Q3 2022.
- Historically, Cash & Current Investments has averaged $57.5 million across 5 years, with a median of $59.4 million in 2024.
- Across the five-year window, Cash & Current Investments slumped 94.52% in 2022 and soared 486764.51% in 2023, its largest moves.
- Year by year, Cash & Current Investments stood at $88.3 million in 2022, then fell by 1.45% to $87.0 million in 2023, then tumbled by 31.67% to $59.4 million in 2024, then decreased by 18.26% to $48.6 million in 2025, then advanced by 1.01% to $49.1 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $49.1 million in Q1 2026, $48.6 million in Q4 2025, and $59.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | OmniAb | 260.98 Mn | 211.91 Mn | 14.41 Mn | 49.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.07 Mn |
| Dec 31, 2025 | 48.58 Mn |
| Sep 30, 2025 | 59.50 Mn |
| Jun 30, 2025 | 41.62 Mn |
| Mar 31, 2025 | 43.60 Mn |
| Dec 31, 2024 | 59.43 Mn |
| Sep 30, 2024 | 59.38 Mn |
| Jun 30, 2024 | 57.23 Mn |
| Mar 31, 2024 | 69.01 Mn |
| Dec 31, 2023 | 86.98 Mn |
| Sep 30, 2023 | 96.63 Mn |
| Jun 30, 2023 | 103.15 Mn |
| Mar 31, 2023 | 113.61 Mn |
| Dec 31, 2022 | 88.27 Mn |
| Sep 30, 2022 | 19,847.00 |
| Jun 30, 2022 | 159,194.00 |
| Mar 31, 2022 | 434,629.00 |
| Sep 30, 2021 | 362,203.00 |
| Jun 30, 2021 | 36,145.00 |